|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:SET-WAPL (FusionGDB2 ID:80973) |
Fusion Gene Summary for SET-WAPL |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: SET-WAPL | Fusion gene ID: 80973 | Hgene | Tgene | Gene symbol | SET | WAPL | Gene ID | 6418 | 23063 |
| Gene name | SET nuclear proto-oncogene | WAPL cohesin release factor | |
| Synonyms | 2PP2A|I2PP2A|IGAAD|IPP2A2|MRD58|PHAPII|TAF-I|TAF-IBETA | FOE|KIAA0261|WAPAL | |
| Cytomap | 9q34.11 | 10q23.2 | |
| Type of gene | protein-coding | protein-coding | |
| Description | protein SETHLA-DR-associated protein IISET nuclear oncogeneSET translocation (myeloid leukemia-associated)Template-Activating Factor-I, chromatin remodelling factorchromatin remodelling factorinhibitor of granzyme A-activated DNaseinhibitor-2 of pr | wings apart-like protein homologfriend of EBNA2 (Epstein-Barr virus nuclear protein 2)friend of EBNA2 protein | |
| Modification date | 20200313 | 20200327 | |
| UniProtAcc | SETD9 | . | |
| Ensembl transtripts involved in fusion gene | |||